Skip to Content

New Drug Approvals Archive - May 2008

May 2008

May 8

Strattera (atomoxetine)

New Indication Approved: May 7, 2008

May 9

Abilify (aripiprazole)

New Indication Approved: May 6, 2008

May 9

Abilify (aripiprazole)

New Indication Approved: May 6, 2008

May 9

OraVerse (phentolamine mesylate) Injection

Date of Approval: May 9, 2008
Company: Novalar Pharmaceuticals, Inc.
Treatment for: Reversal of Anesthesia

OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

OraVerse (phentolamine mesylate) FDA Approval History

May 12

Taclonex (calcipotriene and betamethasone dipropionate)

New Dosage Form Approved: May 9, 2008

Taclonex (calcipotriene and betamethasone dipropionate) FDA Approval History

May 13
May 14

Seroquel (quetiapine)

New Indication Approved: May 13, 2008

May 20

Entereg (alvimopan) Capsules

Date of Approval: May 20, 2008
Company: Adolor Corporation
Treatment for: Postoperative Ileus

Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

Entereg (alvimopan) FDA Approval History

New Drug Approvals Archive